The degree of formality in a risk management process should be customized to the organization’s particular needs and the risks involved.
Darshana Patel
Advertisement
Darshana Patel is an associate director in Global Quality at Merck & Co., Inc.
Articles by Darshana Patel
Advertisement
Latest Updated Articles
Navigating the Formality Spectrum in ICH Q9(R1)Published: July 3rd 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
5
